Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the beginning of 2018. Several of the CTS client forms specify list the Medical Director in the header and these forms will be updated on March 5, 2018. Check out the Communication page for a complete list of forms or by clicking the link below: Communications
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...